Fear of Cancer Recurrence in Genitourinary Cancer
Sponsor
Ludwig-Maximilians - University of Munich (Other)
Overall Status
Recruiting
CT.gov ID
NCT04535921
Collaborator
(none)
500
1
32.9
15.2
Study Details
Study Description
Brief Summary
To perform an analysis of independent predictors of fear of cancer recurrence in patients with malignant genitourinary diseases and their impact on quality of life and survival
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Fear of Cancer Recurrence in Malignant Diseases of the Genitourinary Tract
Actual Study Start Date
:
Nov 5, 2019
Actual Primary Completion Date
:
Apr 30, 2021
Anticipated Study Completion Date
:
Aug 1, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Prostatectomy FCR7 questionnaire pre and postoperative |
Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence
|
Cystectomy FCR7 questionnaire pre and postoperative, 6 months follow |
Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence
|
Nephrectomy FCR7 questionnaire pre and postoperative |
Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence
|
Orchidectomy FCR7 questionnaire pre and postoperative |
Other: FCR7 questionnaire
A 7 item questionnaire about fear of cancer recurrence
|
Outcome Measures
Primary Outcome Measures
- Changes in fear of cancer recurrence pre- and postoperatively [7 to 10 days after initial surgery]
Changes in the FCR7 score pre- and postoperatively
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- histologically confirmed diagnosis of either prostate, urothelial cell, testicular or renal cell cancer
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ludwig-Maximilian-Universität | Munich | Bavaria | Germany | 80796 |
Sponsors and Collaborators
- Ludwig-Maximilians - University of Munich
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Yannic Volz,
Assistant doctor,
Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT04535921
Other Study ID Numbers:
- FCR2020
First Posted:
Sep 2, 2020
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: